Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06541951 · ClinicalTrials.gov registry record · NA
Scaling up Maternal Health Equity Best Practices
A NA study of Maternal Mortality Disparities and Maternal Morbidity Disparities, sponsored by Michigan State University.
- Recruiting
- Registry status
- NA
- Development phase
- 600
- Enrollment target
- 1
- Study location
NCT06541951: Recruiting NA study of Maternal Mortality Disparities and Maternal Morbidity Disparities, sponsored by Michigan State University.
NCT06541951 is a NA study of Maternal Mortality Disparities and Maternal Morbidity Disparities that is actively recruiting participants, run by Michigan State University. The registered enrollment target is 600 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06541951, a NA study of Maternal Mortality Disparities and Maternal Morbidity Disparities, is actively recruiting participants, sponsored by Michigan State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
This study works with prenatal and postnatal care providers in 12 Michigan counties to scale up best practices for maternal health equity.
Primary Outcome
A composite variable reflecting all pregnancy-related and associated morbidity and mortality conditions from pregnancy through 12 months postpartum, assessed using Medicaid claims data. The investigators will assess overall rates for African-American/Hispanic people and their rates relative to non-Hispanic white ones.
Conditions Studied
Interventions
- OTHER Services as usual
- OTHER Scale-up implementation approach
Study Locations (1)
Michigan
- Michigan State University on behalf on 12 Michigan counties - Flint
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2024-11-01 |
| Est. Completion | 2030-11 |
| Phase | NA |
What NCT06541951 shows while recruiting
NCT06541951 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower).
The record links to 2 conditions, with Maternal Mortality Disparities appearing as the primary indexed condition, and to 2 interventions - of which Services as usual is the first listed.
NCT06541951 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06541951 about?
NCT06541951 is a clinical study titled "Scaling up Maternal Health Equity Best Practices". This study works with prenatal and postnatal care providers in 12 Michigan counties to scale up best practices for maternal health equity.
What is the current status of trial NCT06541951?
This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2024-11-01. Estimated completion is 2030-11.
What conditions does trial NCT06541951 study?
This clinical trial studies the following conditions: Maternal Mortality Disparities, Maternal Morbidity Disparities.
What interventions are being tested in trial NCT06541951?
The interventions under investigation include: Services as usual (OTHER), Scale-up implementation approach (OTHER).
Who is sponsoring clinical trial NCT06541951?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06541951 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06541951's enrollment target sits among peer trials
600 162nd of 2000 higher than 1,827 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI